Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 170 participants.
Also called NCT03076112
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 170 participants
- Registry
-
NCT03076112
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03076112. Randomized; no masking; primary purpose treatment. Start 2017-04-25 (actual); primary completion 2022-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Ipragliflozin
- Intervention (Drug)
- Sitagliptin
- Lead sponsor
- Seoul National University Bundang Hospital
- Collaborator
- Astellas Pharma Korea, Inc.
Record details
- Record id
cardio:ct-nct03076112- Content hash
774040a346b7abbc011cceae53baa64d20489cfafcc542bab15c791f9d791469